title: Successful conservative treatment: multiple atypical fractures in osteoporotic patients after bisphosphate medication: a unique case report.
abstract: Bisphosphonates have been commonly used for the treatment of osteoporosis. However, there have been recent case reports of atypical fractures citing their long-term use, which inhibits the turnover of bone components. A 64-year-old woman visited the outpatient clinic with pain in her right thigh and ambulation difficulty. We found fractures at both pedicles of L4 vertebra. subtrochanteric region of right femur, and left femoral shaft upon a radiologic examination. She had taken intravenous ibandronic sodium for osteoporosis over 3 years. We changed the bishophonates to a parathyroid hormone because it was suspected that the multiple fractures were caused by the medication. Further, rehabilitation, including progressive weight bearing, was started. After 3 months of the conservative treatment, she was able to walk independently. In conclusion, it is necessary to evaluate the possibility of atypical fractures in osteoporotic patients when they complain of lower extremity pain and to consider alternative treatments instead of bisphosphonates.
authors: From the Department of Physical and Rehabilitation Medicine (H-SK, H-yJ, M-OK, K-LJ, S-YK, C-HK); and Department of Radiology (YJK), School of Medicine, Inha University, Incheon, Republic of Korea.
authors: Hyo-Sang
authors: HS
authors: Kim
authors: Han Young
authors: HY
authors: Jung
authors: Myeong-Ok
authors: MO
authors: Kim
authors: Kyung-Lim
authors: KL
authors: Joa
authors: Yeo Ju
authors: YJ
authors: Kim
authors: Su-Yeon
authors: SY
authors: Kwon
authors: Chang-Hwan
authors: CH
authors: Kim
mesh_terms: D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005269:Femur; D050723:Fractures, Bone / Q000139:chemically induced*; D006801:Humans; D000077557:Ibandronic Acid; D008159:Lumbar Vertebrae; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D000077557:Ibandronic Acid
references: JAMA. 2011 Feb 23;305(8):783-9
references: 21343577
references: J Nucl Med. 2009 Aug;50(8):1385; author reply 1385
references: 19617329
references: N Engl J Med. 1995 Nov 30;333(22):1437-43
references: 7477143
references: AJNR Am J Neuroradiol. 2010 Apr;31(4):668-73
references: 20019106
references: Radiology. 1996 May;199(2):541-9
references: 8668809
references: N Engl J Med. 2011 May 5;364(18):1728-37
references: 21542743
references: CMAJ. 2010 Nov 23;182(17):1864-73
references: 20940232
references: Osteoporos Int. 2009 Aug;20(8):1353-62
references: 19066707
references: Arch Intern Med. 2012 Jun 25;172(12):936-7
references: 22732750
references: Clin Nucl Med. 2013 May;38(5):397-9
references: 23478849
references: Clin Orthop Relat Res. 2010 Dec;468(12):3384-92
references: 20809164
references: N Engl J Med. 2007 Nov 1;357(18):1799-809
references: 17878149
references: Spine (Phila Pa 1976). 2011 Dec 15;36(26):E1769-73
references: 21415813
references: Mayo Clin Proc. 2008 Sep;83(9):1032-45
references: 18775204
references: Endocr Pract. 2010 Nov-Dec;16 Suppl 3:1-37
references: 21224201
references: Acta Orthop. 2009 Aug;80(4):413-5
references: 19568963
references: Curr Rheumatol Rep. 2003 Feb;5(1):65-74
references: 12590887
references: Eur Spine J. 2009 Jul;18 Suppl 2:206-9
references: 19005693
references: Ann Intern Med. 2008 Sep 16;149(6):404-15
references: 18794560
references: J Rheumatol. 2008 Jul;35(7):1391-7
references: 18528958